Universitat De Les Illes Balears

Other

Universidad De Las Islas Baleares

Antonia Costa Bauza

Rafael M Prieto Almirall

Joan Perello Bestard

Bernat Isern Amengual

Félix Grases Freixedas

Fernando Tur Espinosa

Felix Grases Freixedas

Isabel Gomila Muñiz

Pilar Sanchis Cortes

Laura Garcia Ferragut

Joan Gabriel March Isern

Isabel Gomila Muniz

This invention relates to a composition that comprises inositol phosphates and/or bisphosphonates, and to the use thereof to prevent the loss of substances of biological interest in the body of patients subjected to dialysis and to maintain sufficient physiological levels of said substances to regulate physiological and/or pathological processes, these substances being inhibitors of pathological crystallization.

Composition of dialysis liquid comprising crystallisation inhibitor substances

The invention relates to a fixed-dose association of phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans.

Fixed-dose association of phytate and zinc

The invention relates to a fixed-dose association of 5 phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said 10 association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans.

Process for evaluating the global capacity of urine to form chalky renal

Growing community of inventors

Palma De Mallorca, Spain

Antonia Costa Bauza